Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on March 14, 2013, to discuss financial results of the fourth quarter and year ended December 31, 2012. Frank Condella, president and chief executive officer, and Jonathan Lloyd Jones, vice president, chief financial officer, treasurer and secretary of Columbia Laboratories, will host the call.
|Date:||Thursday, March 14, 2013|
|Time:||11:00 a.m. Eastern Time|
|Dial-in numbers:||(877) 303-9483 (U.S. & Canada) or (760) 666-3584|
www.columbialabs.com under the 'Investors' tab
The teleconference replay will be available two hours after completion through Thursday, March 21, 2013, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 11511952. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investor' section under 'Events'.
About Columbia Laboratories
Columbia Laboratories, Inc. is a specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts